v3.26.1
Subsequent Event - Additional Information (Details) - USD ($)
Mar. 31, 2026
Feb. 12, 2026
Dec. 31, 2025
Nov. 18, 2025
Subsequent Event [Line Items]        
Nominal value $ 0.01   $ 0.01  
Avadel Pharmaceuticals Plc        
Subsequent Event [Line Items]        
Issued ordinary share   $ 21    
Nominal value   0.01    
Potential additional cash payment per share upon achievement of specific milestone   1.5    
Potential additional cash payment per share   $ 21    
Bridge Term Loan Credit Agreement | JPMorgan Chase Bank, N.A. | Avadel Pharmaceuticals Plc        
Subsequent Event [Line Items]        
Aggregate principal amount       $ 1,500,000,000